These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 12115482)
1. DNA topoisomerase IIalpha predicts progression-free and overall survival in pediatric malignant non-brainstem gliomas. Bredel M; Pollack IF; Hamilton RL; Birner P; Hainfellner JA; Zentner J Int J Cancer; 2002 Jun; 99(6):817-20. PubMed ID: 12115482 [TBL] [Abstract][Full Text] [Related]
2. DNA topoisomerase IIalpha and Her-2/neu gene dosages in pediatric malignant gliomas. Bredel C; Lassmann S; Pollack IF; Knoth R; Hamilton RL; Volk B; Werner M; Bredel M Int J Oncol; 2005 May; 26(5):1187-92. PubMed ID: 15809708 [TBL] [Abstract][Full Text] [Related]
3. Proliferation index as a predictor of prognosis in malignant gliomas of childhood. Pollack IF; Campbell JW; Hamilton RL; Martinez AJ; Bozik ME Cancer; 1997 Feb; 79(4):849-56. PubMed ID: 9024724 [TBL] [Abstract][Full Text] [Related]
4. Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome. Preusser M; Wolfsberger S; Czech T; Slavc I; Budka H; Hainfellner JA Am J Clin Pathol; 2005 Oct; 124(4):543-9. PubMed ID: 16146813 [TBL] [Abstract][Full Text] [Related]
5. High expression of DNA topoisomerase IIalpha and Ki-67 antigen is associated with prolonged survival in glioblastoma patients. Bredel M; Piribauer M; Marosi C; Birner P; Gatterbauer B; Fischer I; Ströbel T; Rössler K; Budka H; Hainfellner JA Eur J Cancer; 2002 Jul; 38(10):1343-7. PubMed ID: 12091064 [TBL] [Abstract][Full Text] [Related]
6. DNA topoisomerase II-alpha as a proliferation marker in human gliomas: correlation with PCNA expression and patient survival. Zhao H; Yu H; Liu Y; Wang Y; Cai W Clin Neuropathol; 2008; 27(2):83-90. PubMed ID: 18402387 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas. Taniguchi K; Wakabayashi T; Yoshida T; Mizuno M; Yoshikawa K; Kikuchi A; Nakashima N; Yoshida J J Neurosurg; 1999 Sep; 91(3):477-82. PubMed ID: 10470824 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of survivin and DNA topoisomerase IIα in diffuse and anaplastic astrocytomas. Varughese RK; Skjulsvik AJ; Torp SH Pathol Res Pract; 2017 Apr; 213(4):339-347. PubMed ID: 28214203 [TBL] [Abstract][Full Text] [Related]
9. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status. Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587 [TBL] [Abstract][Full Text] [Related]
10. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer. Dingemans AM; Witlox MA; Stallaert RA; van der Valk P; Postmus PE; Giaccone G Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Evaluation of Minichromosome Maintenance Protein 7 (MCM7), Topoisomerase IIα, and Ki-67 in Diffuse Malignant Peritoneal Mesothelioma Patients Using Tissue Microarray. Deraco M; Cabras A; Baratti D; Kusamura S Ann Surg Oncol; 2015 Dec; 22(13):4344-51. PubMed ID: 25777091 [TBL] [Abstract][Full Text] [Related]
12. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort. Pollack IF; Hamilton RL; Sobol RW; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL J Clin Oncol; 2006 Jul; 24(21):3431-7. PubMed ID: 16849758 [TBL] [Abstract][Full Text] [Related]
13. DNA topoisomerase IIα and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery. Winther TL; Torp SH PLoS One; 2017; 12(3):e0172316. PubMed ID: 28301542 [TBL] [Abstract][Full Text] [Related]
14. DNA topoisomerase II-alpha as a proliferation marker in astrocytic neoplasms of the central nervous system: correlation with MIB1 expression and patient survival. Holden JA; Townsend JJ Mod Pathol; 1999 Dec; 12(12):1094-100. PubMed ID: 10619260 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of Ki-67 and topoisomerase IIalpha expression in infiltrating ductal carcinoma of the breast. A multivariate analysis of 863 cases. Rudolph P; MacGrogan G; Bonichon F; Frahm SO; de Mascarel I; Trojani M; Durand M; Avril A; Coindre JM; Parwaresch R Breast Cancer Res Treat; 1999 May; 55(1):61-71. PubMed ID: 10472780 [TBL] [Abstract][Full Text] [Related]
16. Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial. Erber R; Gluz O; Brünner N; Kreipe HH; Pelz E; Kates R; Bartels A; Huober J; Mohrmann S; Moustafa Z; Liedtke C; Möbus V; Augustin D; Thomssen C; Jänicke F; Kiechle M; Kuhn W; Nitz U; Harbeck N; Hartmann A Breast Cancer Res Treat; 2015 Apr; 150(2):279-88. PubMed ID: 25721604 [TBL] [Abstract][Full Text] [Related]
17. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival. Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366 [TBL] [Abstract][Full Text] [Related]
18. DNA topoisomerase IIalpha expression in optic pathway gliomas of childhood. Bredel M; Slavc I; Birner P; Czech T; Haberler C; Ströbel T; Wolfsberger S; Budka H; Hainfellner JA Eur J Cancer; 2002 Feb; 38(3):393-400. PubMed ID: 11818205 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional expression of glioma chemotherapy drugs associated marker molecules in gliomas and normal brain tissues. Zhao Y; Xue Y; Zhang Q; Wang K; Yin J; Lou M Cancer Biomark; 2013; 13(1):59-66. PubMed ID: 23736022 [TBL] [Abstract][Full Text] [Related]
20. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors. Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]